Results 101 to 110 of about 3,981,458 (213)

Dialysis Toolkit for Severe Thrombocytopenia in Patients with Acute Kidney Injury

Journal of the Pakistan Medical Association
Acute kidney injury (AKI) in the setting of severe thrombocytopenia represents a formidable challenge in nephrology, where both the underlying disease and therapeutic interventions carry a high risk of bleeding.
Sourabh Sharma, Intissar Haddiya, Dina A Abdellatif, Sanjay Kalra   +3 more
doaj   +1 more source

Toxicity of Cytarabine Intravenous Constant Rate Infusion in Cats With Lymphoma

Veterinary and Comparative Oncology, EarlyView.
ABSTRACT Cytarabine intravenous constant rate infusion (IV CRI) toxicity in cats with lymphoma has not been well documented. We aimed to assess toxicities following cytarabine IV CRI as a single‐agent or within a multiagent protocol in cats with lymphoma. Medical records of cats with lymphoma treated with cytarabine IV CRI, with documented dose, route,
Rachel Hanford, Katherine A. Skorupski, Robert B. Rebhun, Rachel V. Brady, Sami Al‐Nadaf, Amandine T. Lejeune   +5 more
wiley   +1 more source

Heparin-induced thrombocytopenia: An Update

, 1970
Heparin-induced thrombocytopenia (HIT) is the most important and most frequent drug-induced, immune-mediated type of thrombocytopenia. It is associated with significant morbidity and mortality if unrecognized.
M Ullah, LA Sayami
core   +1 more source

Prospective Observational Study on the Risk Factors of Chemotherapy-Induced Myelosuppression and Its Management in a Tertiary Care Hospital

Indian Journal of Medical and Paediatric Oncology
Introduction Myelosuppression is a commonly observed dose-limiting side effect of majority of chemotherapeutic drugs, characterized by a decrease in blood cell production.
D. Keziah, M. Bindhiya, M. Jayaprakash, Rodrigues A. Prudence   +3 more
doaj   +1 more source

Adjuvant gonadotropin releasing hormone analog in gonadotoxic chemotherapy for preservation of fertility

Indian Journal of Endocrinology and Metabolism, 2013
Chemotherapy induced infertility is a problem which is growing and often neglected. Fertility preservation strategy is an important component of the management in young patients with cancer.
K. V. S. Hari Kumar, Altamash Shaikh
doaj   +1 more source

Synergistic Regulation of Biomaterials and Macrophages: A Novel Paradigm in Immunotherapy

MedComm – Biomaterials and Applications, Volume 5, Issue 4, December 2026.
Bioengineered materials mediating the modulation of macrophage plasticity and inflammatory signals in the tumor microenvironment effectively remodel immunoregulatory states, boost antitumor immunity, and promote tissue repair, achieving synergistic therapeutic outcomes.
Jiayu Zhang, Songhang Xing, Shanshan Zhang, Yuan Hao, Xiaojie Qu, Wurihan Bao, Manwei Hao, Han Sun, Mingyuan Dong, Huiling Zhang, Dan Huang, Yiqi Wang, Xuanjie Jiang, Xiaoyu Pu, Yanyan Chi, Xingtong Wang, Xuefeng Li   +16 more
wiley   +1 more source

Thrombopoietin-Receptor Agonism in Chemotherapy-Induced Thrombocytopenia

International Journal of Contemporary Pathology
Chemotherapy-induced thrombocytopenia (CIT) is a common, dose-limiting toxicity of cytotoxic cancer therapy that frequently necessitates dose reduction, delay, or discontinuation, thereby compromising relative dose intensity and potentially diminishing therapeutic efficacy. Existing management strategies are largely supportive and do not address the
openaire   +1 more source

Venous Thromboembolism in Hematologic Malignancies: Incidence, Risk Factors, and the Role of Direct Oral Anticoagulants

European Journal of Haematology, Volume 117, Issue 6, Page 1421-1441, December 2026.
ABSTRACT Thrombotic events, particularly venous thromboembolism (VTE), are a significant source of morbidity and mortality among patients with hematologic malignancies. These patients face unique challenges due to treatment‐related complications such as thrombocytopenia, coagulopathy, and heightened bleeding risk.
Mario Biglietto, Silvia Sorella, Erminia Baldacci, Massimo Breccia, Sabina Chiaretti, Marcello Capriata, Livia Donzelli, Gianna Maria D'Elia, Salvatore Giacomo Morano, Ilaria Del Giudice, Maurizio Martelli, Cristina Santoro, Antonio Chistolini   +12 more
wiley   +1 more source

Eosinophilia and Hypereosinophilia: A Practical Approach to Navigating a Broad Differential Diagnosis

European Journal of Haematology, Volume 117, Issue 6, Page 1485-1499, December 2026.
ABSTRACT Eosinophilia, defined as an absolute eosinophil count (AEC) of ≥ 0.5 × 109/L, is a frequently encountered finding with a vast spectrum of potential underlying etiologies. Hypereosinophilia (HE) is defined as AEC > 1.5 × 109/L and may become life‐threatening when eosinophil‐induced organ damage occurs, defining the hypereosinophilic syndrome ...
Stijn Wigerinck, Peter Vandenberghe
wiley   +1 more source

Romiplostim for temozolomide-induced thrombocytopenia in glioblastoma: The PLATUM trial [PDF]

, 2019
OBJECTIVE To determine the efficacy of the thrombopoietin receptor agonist romiplostim for the prevention of temozolomide-induced thrombocytopenia in newly diagnosed glioblastoma.
Chinot, Olivier, Reyns, Nicolas, Lepage, Clément, Di Stefano, Anna Luisa, Le Rhun, Emilie, Weller, Michael, Devos, Patrick, Cartalat, Stéphanie, Dubois, François, Houillier, Caroline, Weller M, Di Stefano AL, Reyns N, Houillier C, Cartalat S, Le Rhun E, Chinot O, Devos P, Lepage C, Dubois F   +19 more
core   +1 more source